-
1رسالة جامعية
المؤلفون: Herron-McCoy, La-Monica
المصدر: ProQuest LLC. 2009Ph.D. Dissertation, The University of Alabama.
Peer Reviewed: N
Page Count: 173
Descriptors: Ethnicity, Reading Attitudes, Reading Achievement, Academic Achievement, Achievement Gap, Student Motivation, White Students, Elementary School Students, Gender Differences, Socioeconomic Status, Student Attitudes, Rural Areas, Measures (Individuals), Correlation, Social Capital, Cultural Capital, Scores, African American Students, Achievement Tests
-
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3دورية أكاديمية
المؤلفون: Wahid KA; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., He R; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., McDonald BA; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Anderson BM; Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Salzillo T; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Mulder S; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Wang J; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Sharafi CS; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., McCoy LA; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Naser MA; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ahmed S; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Sanders KL; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Mohamed ASR; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ding Y; Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Wang J; Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hutcheson K; Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Lai SY; Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Fuller CD; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., van Dijk LV; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
المصدر: Physics and imaging in radiation oncology [Phys Imaging Radiat Oncol] 2021 Nov 20; Vol. 20, pp. 88-93. Date of Electronic Publication: 2021 Nov 20 (Print Publication: 2021).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101704276 Publication Model: eCollection Cited Medium: Internet ISSN: 2405-6316 (Electronic) Linking ISSN: 24056316 NLM ISO Abbreviation: Phys Imaging Radiat Oncol Subsets: PubMed not MEDLINE
-
4دورية أكاديمية
المؤلفون: van Dijk LV; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Mohamed ASR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ferrarotto R; Division of Cancer Medicine, Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., McCoy LA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; College of Medicine, University of Houston, Houston, Texas., Sharafi CS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jones E; Texas Undergraduate Medical Academy, Prairie View A&M University, Prairie View, Texas., Steele K; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Texas Undergraduate Medical Academy, Prairie View A&M University, Prairie View, Texas., Moreno AC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lai SY; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas., Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Myers JN; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas., Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hutcheson KA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
مؤلفون مشاركون: MD Anderson Symptom Working Group
المصدر: Cancer [Cancer] 2021 Jul 15; Vol. 127 (14), pp. 2453-2464. Date of Electronic Publication: 2021 Mar 31.
نوع المنشور: Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
-
5دورية أكاديمية
المؤلفون: Effron MB; US Medical Affairs-Cardiovascular, Eli Lilly and Company, Indianapolis, Indiana.; Department of Cardiology, John Ochsner Heart and Vascular Institute, Ochsner Medical Center, New Orleans, Louisiana., Wang TY; Duke Clinical Research Institute, Durham, North Carolina., Fonarow GC; Division of Cardiology, Ronald Reagan UCLA Medical Center, Los Angeles, California., Henry TD; Division of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California.; Division of Cardiology, Minneapolis Heart Institute, Minneapolis, Minnesota., Zettler ME; US Medical Affairs-Cardiovascular, Eli Lilly and Company, Indianapolis, Indiana., Baker BA; Daiichi Sankyo Inc., Parsippany, New Jersey., McCoy LA; Duke Clinical Research Institute, Durham, North Carolina., Peterson ED; Duke Clinical Research Institute, Durham, North Carolina.
المصدر: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2018 Feb 01; Vol. 91 (2), pp. 242-250. Date of Electronic Publication: 2017 Oct 08.
نوع المنشور: Comparative Study; Journal Article; Multicenter Study; Observational Study
بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 100884139 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-726X (Electronic) Linking ISSN: 15221946 NLM ISO Abbreviation: Catheter Cardiovasc Interv Subsets: MEDLINE
مواضيع طبية MeSH: Community Health Services*/trends , Percutaneous Coronary Intervention*/adverse effects , Percutaneous Coronary Intervention*/mortality , Percutaneous Coronary Intervention*/trends , Practice Patterns, Physicians'*/trends, Clopidogrel/*administration & dosage , Non-ST Elevated Myocardial Infarction/*therapy , Platelet Aggregation Inhibitors/*administration & dosage , Prasugrel Hydrochloride/*administration & dosage , Purinergic P2Y Receptor Antagonists/*administration & dosage , ST Elevation Myocardial Infarction/*therapy, Aged ; Clopidogrel/adverse effects ; Female ; Hemorrhage/chemically induced ; Humans ; Male ; Middle Aged ; Non-ST Elevated Myocardial Infarction/blood ; Non-ST Elevated Myocardial Infarction/diagnosis ; Non-ST Elevated Myocardial Infarction/mortality ; Platelet Aggregation Inhibitors/adverse effects ; Prasugrel Hydrochloride/adverse effects ; Purinergic P2Y Receptor Antagonists/adverse effects ; Risk Factors ; ST Elevation Myocardial Infarction/blood ; ST Elevation Myocardial Infarction/diagnosis ; ST Elevation Myocardial Infarction/mortality ; Time Factors ; Treatment Outcome ; United States
-
6دورية أكاديمية
المؤلفون: Bagai A; Terrence Donnelly Heart Center, St Michael's Hospital, University of Toronto, Ontario, Canada. Electronic address: bagaia@smh.ca., Peterson ED; Duke Clinical Research Institute, Durham, NC., McCoy LA; Duke Clinical Research Institute, Durham, NC., Effron MB; Lilly USA, LLC, Indianapolis, IN., Zettler ME; Lilly USA, LLC, Indianapolis, IN., Stone GW; Columbia University Medical Center, New York, NY., Henry TD; Cedars-Sinai Heart Institute, Los Angeles, CA., Cohen DJ; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City School of Medicine, Kansas City, MO., Schulte PJ; Department of Health Sciences Research, Mayo Clinic, Rochester, MN., Anstrom KJ; Duke Clinical Research Institute, Durham, NC., Wang TY; Duke Clinical Research Institute, Durham, NC.
المصدر: American heart journal [Am Heart J] 2017 May; Vol. 187, pp. 19-28. Date of Electronic Publication: 2017 Feb 10.
نوع المنشور: Journal Article; Multicenter Study; Observational Study
بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744 (Electronic) Linking ISSN: 00028703 NLM ISO Abbreviation: Am Heart J Subsets: MEDLINE
مواضيع طبية MeSH: Blood Platelets/*drug effects , Myocardial Infarction/*drug therapy , Prasugrel Hydrochloride/*therapeutic use , Purinergic P2Y Receptor Antagonists/*therapeutic use , Ticlopidine/*analogs & derivatives, Aged ; Brain Ischemia/chemically induced ; Clopidogrel ; Female ; Hemorrhage/chemically induced ; Humans ; Male ; Middle Aged ; Myocardial Infarction/surgery ; Percutaneous Coronary Intervention ; Platelet Function Tests ; Prasugrel Hydrochloride/adverse effects ; Prospective Studies ; Purinergic P2Y Receptor Antagonists/adverse effects ; Ticlopidine/adverse effects ; Ticlopidine/therapeutic use
-
7دورية أكاديمية
المؤلفون: Dharmarajan K; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States of America.; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, United States of America., Foster J; American College of Cardiology, Washington, DC, United States of America., Coylewright M; Section of Cardiovascular Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH, United States of America., Green P; Division of Cardiology, Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, NY, United States of America., Vavalle JP; Division of Cardiology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America., Faheem O; Prima Care Cardiology, Fall River, MA, United States of America., Huang PH; Sutter Heart & Vascular Institute, Sacramento, CA, United States of America., Krishnaswamy A; Department of Cardiovascular Medicine, Division of Interventional Cardiology, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, United States of America., Thourani VH; Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, GA, United States of America., McCoy LA; Duke Clinical Research Institute, Durham, NC, United States of America., Wang TY; Duke Clinical Research Institute, Durham, NC, United States of America.
المصدر: PloS one [PLoS One] 2017 Apr 21; Vol. 12 (4), pp. e0175926. Date of Electronic Publication: 2017 Apr 21 (Print Publication: 2017).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
مواضيع طبية MeSH: Decision Making* , Patient Participation*, Aortic Valve Stenosis/*surgery , Heart Valve Prosthesis Implantation/*methods, Aged ; Aged, 80 and over ; Cohort Studies ; Female ; Humans ; Male ; Severity of Illness Index
-
8دورية أكاديمية
المؤلفون: Valle JA; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (J.A.V., T.M.M., J.S.R., P.M.H., T.T.T., J.C.M.); Duke Clinical Research Institute, Durham, NC (L.A.M., M.T.R.); Division of Cardiology, Veterans Affairs Eastern Colorado Health Care System, Denver (T.M.M., P.M.H.); Division of Cardiology, Mater Misericordiae University Hospital, Dublin, Ireland (I.P.C.); Division of Cardiovascular Medicine, University of Michigan, Ann Arbor (B.K.N.); Division of Cardiology, Duke University, Durham, NC (M.T.R.); and Department of Cardiology, Institute for Health Research, Kaiser Permanente Colorado, Denver (T.T.T.). javier.valle@ucdenver.edu., McCoy LA; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (J.A.V., T.M.M., J.S.R., P.M.H., T.T.T., J.C.M.); Duke Clinical Research Institute, Durham, NC (L.A.M., M.T.R.); Division of Cardiology, Veterans Affairs Eastern Colorado Health Care System, Denver (T.M.M., P.M.H.); Division of Cardiology, Mater Misericordiae University Hospital, Dublin, Ireland (I.P.C.); Division of Cardiovascular Medicine, University of Michigan, Ann Arbor (B.K.N.); Division of Cardiology, Duke University, Durham, NC (M.T.R.); and Department of Cardiology, Institute for Health Research, Kaiser Permanente Colorado, Denver (T.T.T.)., Maddox TM; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (J.A.V., T.M.M., J.S.R., P.M.H., T.T.T., J.C.M.); Duke Clinical Research Institute, Durham, NC (L.A.M., M.T.R.); Division of Cardiology, Veterans Affairs Eastern Colorado Health Care System, Denver (T.M.M., P.M.H.); Division of Cardiology, Mater Misericordiae University Hospital, Dublin, Ireland (I.P.C.); Division of Cardiovascular Medicine, University of Michigan, Ann Arbor (B.K.N.); Division of Cardiology, Duke University, Durham, NC (M.T.R.); and Department of Cardiology, Institute for Health Research, Kaiser Permanente Colorado, Denver (T.T.T.)., Rumsfeld JS; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (J.A.V., T.M.M., J.S.R., P.M.H., T.T.T., J.C.M.); Duke Clinical Research Institute, Durham, NC (L.A.M., M.T.R.); Division of Cardiology, Veterans Affairs Eastern Colorado Health Care System, Denver (T.M.M., P.M.H.); Division of Cardiology, Mater Misericordiae University Hospital, Dublin, Ireland (I.P.C.); Division of Cardiovascular Medicine, University of Michigan, Ann Arbor (B.K.N.); Division of Cardiology, Duke University, Durham, NC (M.T.R.); and Department of Cardiology, Institute for Health Research, Kaiser Permanente Colorado, Denver (T.T.T.)., Ho PM; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (J.A.V., T.M.M., J.S.R., P.M.H., T.T.T., J.C.M.); Duke Clinical Research Institute, Durham, NC (L.A.M., M.T.R.); Division of Cardiology, Veterans Affairs Eastern Colorado Health Care System, Denver (T.M.M., P.M.H.); Division of Cardiology, Mater Misericordiae University Hospital, Dublin, Ireland (I.P.C.); Division of Cardiovascular Medicine, University of Michigan, Ann Arbor (B.K.N.); Division of Cardiology, Duke University, Durham, NC (M.T.R.); and Department of Cardiology, Institute for Health Research, Kaiser Permanente Colorado, Denver (T.T.T.)., Casserly IP; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (J.A.V., T.M.M., J.S.R., P.M.H., T.T.T., J.C.M.); Duke Clinical Research Institute, Durham, NC (L.A.M., M.T.R.); Division of Cardiology, Veterans Affairs Eastern Colorado Health Care System, Denver (T.M.M., P.M.H.); Division of Cardiology, Mater Misericordiae University Hospital, Dublin, Ireland (I.P.C.); Division of Cardiovascular Medicine, University of Michigan, Ann Arbor (B.K.N.); Division of Cardiology, Duke University, Durham, NC (M.T.R.); and Department of Cardiology, Institute for Health Research, Kaiser Permanente Colorado, Denver (T.T.T.)., Nallamothu BK; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (J.A.V., T.M.M., J.S.R., P.M.H., T.T.T., J.C.M.); Duke Clinical Research Institute, Durham, NC (L.A.M., M.T.R.); Division of Cardiology, Veterans Affairs Eastern Colorado Health Care System, Denver (T.M.M., P.M.H.); Division of Cardiology, Mater Misericordiae University Hospital, Dublin, Ireland (I.P.C.); Division of Cardiovascular Medicine, University of Michigan, Ann Arbor (B.K.N.); Division of Cardiology, Duke University, Durham, NC (M.T.R.); and Department of Cardiology, Institute for Health Research, Kaiser Permanente Colorado, Denver (T.T.T.)., Roe MT; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (J.A.V., T.M.M., J.S.R., P.M.H., T.T.T., J.C.M.); Duke Clinical Research Institute, Durham, NC (L.A.M., M.T.R.); Division of Cardiology, Veterans Affairs Eastern Colorado Health Care System, Denver (T.M.M., P.M.H.); Division of Cardiology, Mater Misericordiae University Hospital, Dublin, Ireland (I.P.C.); Division of Cardiovascular Medicine, University of Michigan, Ann Arbor (B.K.N.); Division of Cardiology, Duke University, Durham, NC (M.T.R.); and Department of Cardiology, Institute for Health Research, Kaiser Permanente Colorado, Denver (T.T.T.)., Tsai TT; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (J.A.V., T.M.M., J.S.R., P.M.H., T.T.T., J.C.M.); Duke Clinical Research Institute, Durham, NC (L.A.M., M.T.R.); Division of Cardiology, Veterans Affairs Eastern Colorado Health Care System, Denver (T.M.M., P.M.H.); Division of Cardiology, Mater Misericordiae University Hospital, Dublin, Ireland (I.P.C.); Division of Cardiovascular Medicine, University of Michigan, Ann Arbor (B.K.N.); Division of Cardiology, Duke University, Durham, NC (M.T.R.); and Department of Cardiology, Institute for Health Research, Kaiser Permanente Colorado, Denver (T.T.T.)., Messenger JC; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (J.A.V., T.M.M., J.S.R., P.M.H., T.T.T., J.C.M.); Duke Clinical Research Institute, Durham, NC (L.A.M., M.T.R.); Division of Cardiology, Veterans Affairs Eastern Colorado Health Care System, Denver (T.M.M., P.M.H.); Division of Cardiology, Mater Misericordiae University Hospital, Dublin, Ireland (I.P.C.); Division of Cardiovascular Medicine, University of Michigan, Ann Arbor (B.K.N.); Division of Cardiology, Duke University, Durham, NC (M.T.R.); and Department of Cardiology, Institute for Health Research, Kaiser Permanente Colorado, Denver (T.T.T.).
المصدر: Circulation. Cardiovascular interventions [Circ Cardiovasc Interv] 2017 Apr; Vol. 10 (4).
نوع المنشور: Journal Article; Multicenter Study
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101499602 Publication Model: Print Cited Medium: Internet ISSN: 1941-7632 (Electronic) Linking ISSN: 19417640 NLM ISO Abbreviation: Circ Cardiovasc Interv Subsets: MEDLINE
مواضيع طبية MeSH: Registries*, Acute Kidney Injury/*epidemiology , Contrast Media/*adverse effects , Coronary Angiography/*adverse effects , Coronary Artery Disease/*surgery , Percutaneous Coronary Intervention/*adverse effects , Postoperative Complications/*epidemiology, Acute Kidney Injury/chemically induced ; Aged ; Coronary Angiography/methods ; Coronary Artery Disease/mortality ; Female ; Follow-Up Studies ; Hospital Mortality/trends ; Humans ; Incidence ; Male ; Prognosis ; Prospective Studies ; Risk Factors ; Survival Rate/trends ; Time Factors ; United States/epidemiology
-
9دورية أكاديمية
المؤلفون: Zettler ME; Eli Lilly & Company, Indianapolis, IN., Peterson ED; Duke Clinical Research Institute, Durham, NC., McCoy LA; Duke Clinical Research Institute, Durham, NC., Effron MB; Eli Lilly & Company, Indianapolis, IN., Anstrom KJ; Duke Clinical Research Institute, Durham, NC., Henry TD; Cedars-Sinai Medical Center, Los Angeles, CA., Baker BA; Daiichi Sankyo, Inc., Parsippany, NJ., Messenger JC; University of Colorado School of Medicine, Aurora, CO., Cohen DJ; Saint Luke's Mid America Heart Institute, Kansas City, MO., Wang TY; Duke Clinical Research Institute, Durham, NC. Electronic address: tracy.wang@dm.duke.edu.
مؤلفون مشاركون: TRANSLATE-ACS Investigators
المصدر: American heart journal [Am Heart J] 2017 Jan; Vol. 183, pp. 62-68. Date of Electronic Publication: 2016 Oct 15.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744 (Electronic) Linking ISSN: 00028703 NLM ISO Abbreviation: Am Heart J Subsets: MEDLINE
مواضيع طبية MeSH: Drug Substitution/*statistics & numerical data , Myocardial Infarction/*drug therapy , Purinergic P1 Receptor Antagonists/*therapeutic use, Adenosine/analogs & derivatives ; Adenosine/therapeutic use ; Adenosine Diphosphate ; Aged ; Cardiovascular Diseases/epidemiology ; Clopidogrel ; Female ; Hemorrhage/chemically induced ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Patient Discharge ; Patient Preference ; Platelet Aggregation Inhibitors/therapeutic use ; Prasugrel Hydrochloride/therapeutic use ; Purinergic P1 Receptor Antagonists/adverse effects ; Purinergic P1 Receptor Antagonists/economics ; Ticagrelor ; Ticlopidine/analogs & derivatives ; Ticlopidine/therapeutic use
-
10دورية أكاديمية
المؤلفون: Jackson LR 2nd; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC larry.jackson@dm.duke.edu., Peterson ED; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC., McCoy LA; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC., Ju C; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC., Zettler M; Eli Lilly & Company, Indianapolis, IN., Baker BA; Daiichi Sankyo, Inc, Parsippany, NJ., Messenger JC; University of Colorado School of Medicine, Aurora, CO., Faries DE; Eli Lilly & Company, Indianapolis, IN., Effron MB; Eli Lilly & Company, Indianapolis, IN., Cohen DJ; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City School of Medicine, Kansas City, MO., Wang TY; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC.
المصدر: Journal of the American Heart Association [J Am Heart Assoc] 2016 Oct 21; Vol. 5 (10). Date of Electronic Publication: 2016 Oct 21.
نوع المنشور: Comparative Study; Journal Article
بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE
مواضيع طبية MeSH: Acute Coronary Syndrome/*drug therapy , Myocardial Infarction/*drug therapy , Prasugrel Hydrochloride/*therapeutic use , Proton Pump Inhibitors/*therapeutic use , Purinergic P2Y Receptor Antagonists/*therapeutic use , Ticlopidine/*analogs & derivatives, Acute Coronary Syndrome/surgery ; Aftercare ; Aged ; Cardiovascular Diseases/mortality ; Clopidogrel ; Comparative Effectiveness Research ; Female ; Gastrointestinal Hemorrhage/chemically induced ; Gastrointestinal Hemorrhage/epidemiology ; Hemorrhage/chemically induced ; Hemorrhage/epidemiology ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Myocardial Infarction/surgery ; Myocardial Revascularization/statistics & numerical data ; Percutaneous Coronary Intervention ; Platelet Aggregation Inhibitors/therapeutic use ; Proportional Hazards Models ; Recurrence ; Stroke/epidemiology ; Ticlopidine/therapeutic use ; Treatment Outcome